1. World Health Organization. (2004). WHO Report 2004 Global Tuberculosis Control Surveillance, Planning, Financing. WHO/HTM/TB/2004.331. WHO, Geneva, Switzerland.
2. World Health Organization. (2004). Anti-tuberculosis Drug Resistance in the World: Report No. 3. Prevalence and Trends. The WHO/IUATLD Global Project on Anti-tuberculosis Drug Resistance Surveillance. WHO/CDS/TB/2004. WHO, Geneva, Switzerland, in press.
3. Kent, P. T. & Kubica, G. P. (1985). Public health mycobacteriology. A guide for the level III laboratory. U.S. Department of Health and Human Services, Centers for Disease Control and Prevention. Atlanta, GA, USA.
4. Roberts, G. D., Goodman, N. L., Heifets, L. et al. (1983). Evaluation of the BACTEC radiometric method for recovery of mycobacteria and drug susceptibility testing of Mycobacterium tuberculosis from acid-fast smear-positive specimens. Journal of Clinical Microbiology18, 689–96.
5. McNerney, R., Kiepiela, P., Bishop, K. S. et al. (2000). Rapid screening of Mycobacterium tuberculosis for susceptibility to rifampicin and streptomycin. International Journal of Tuberculosis and Lung Disease4, 69–75.